Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Short Communication Volume 5 Issue 10

Nanoparticles and Targeted Cancer Therapy

Yadav Ajay Kumar1,2*, Gnawali Suman2 and Yuan Gangbiao1

1Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, China
2Department of Radio-Diagnosis, Imaging and Nuclear Medicine, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal

*Corresponding Author: Yadav Ajay Kumar, Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, China.

Received: August 27, 2021; Published: September 18, 2021

Abstract

  Nanoscale devices are 100 to 10 thousand-fold smaller than human cells. They’re similar in size to massive biological molecules ("biomolecules") like enzymes and receptors. As AN example, hemoglobin, the molecule that carries atomic number 8 in red blood cells, is close to five nanometers in diameter. Nanoscale devices smaller than fifty nanometers will simply enter most cells, whereas those smaller than twenty nanometers will move out of blood vessels as they flow into through the body. Attributable to their tiny size, nanoparticles will promptly perform with biomolecules on each the surface and within cells. By gaining access to numerous areas of the body, they need the potential to discover malady and deliver treatment in ways in which undreamt of previously.

References

  1. https://www.cancer.gov/nano/cancer-nanotechnology/treatment

Citation

Citation: Yadav Ajay Kumar., et al. “Nanoparticles and Targeted Cancer Therapy". Acta Scientific Cancer Biology 5.10 (2021): 16-18.

Copyright

Copyright: © 2021 Yadav Ajay Kumar., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US